Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Nat Med

Retrieve available abstracts of 17 articles:
HTML format

Single Articles

    May 2021
  1. ERONDU NA, Aniebo I, Kyobutungi C, Midega J, et al
    Open letter to international funders of science and development in Africa.
    Nat Med. 2021;27:742-744.

    March 2021
    Reducing the price tag on malaria vector control.
    Nat Med. 2021 Mar 25. pii: 10.1038/d41591-021-00016.

    February 2021
  3. MURIUKI JM, Mentzer AJ, Mitchell R, Webb EL, et al
    Malaria is a cause of iron deficiency in African children.
    Nat Med. 2021 Feb 22. pii: 10.1038/s41591-021-01238.
    PubMed     Abstract available

    November 2020
  4. BEJON P
    Malaria parasites hide in plain sight in the dry season.
    Nat Med. 2020 Nov 23. pii: 10.1038/s41591-020-01171.

    October 2020
  5. ANDRADE CM, Fleckenstein H, Thomson-Luque R, Doumbo S, et al
    Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season.
    Nat Med. 2020 Oct 26. pii: 10.1038/s41591-020-1084.
    PubMed     Abstract available

    September 2020
  6. ANSUMANA R, Sankoh O, Zumla A
    Effects of disruption from COVID-19 on antimalarial strategies.
    Nat Med. 2020;26:1334-1336.

    August 2020
  7. SHERRARD-SMITH E, Hogan AB, Hamlet A, Watson OJ, et al
    The potential public health consequences of COVID-19 on malaria in Africa.
    Nat Med. 2020 Aug 7. pii: 10.1038/s41591-020-1025.
    PubMed     Abstract available

  8. UWIMANA A, Legrand E, Stokes BH, Ndikumana JM, et al
    Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda.
    Nat Med. 2020 Aug 3. pii: 10.1038/s41591-020-1005.
    PubMed     Abstract available

    May 2020
  9. MURUGAN R, Scally SW, Costa G, Mustafa G, et al
    Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.
    Nat Med. 2020 May 25. pii: 10.1038/s41591-020-0881.
    PubMed     Abstract available

  10. LONGLEY RJ, White MT, Takashima E, Brewster J, et al
    Development and validation of serological markers for detecting recent Plasmodium vivax infection.
    Nat Med. 2020;26:741-749.
    PubMed     Abstract available

    October 2019
  11. BRASIL P
    Never shy from infectious-disease mysteries.
    Nat Med. 2019;25:1465.

    December 2018
  12. KISALU NK, Idris AH, Weidle C, Flores-Garcia Y, et al
    Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.
    Nat Med. 2018 Dec 14. pii: 10.1038/s41591-018-0315.
    PubMed     Abstract available

    April 2018
  13. DRAPER SJ, Higgins MK
    A new site of attack for a malaria vaccine.
    Nat Med. 2018;24:382-383.

    March 2018
  14. TAN J, Sack BK, Oyen D, Zenklusen I, et al
    A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein.
    Nat Med. 2018 Mar 19. pii: nm.4513. doi: 10.1038/nm.4513.
    PubMed     Abstract available

  15. KISALU NK, Idris AH, Weidle C, Flores-Garcia Y, et al
    A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.
    Nat Med. 2018 Mar 19. pii: nm.4512. doi: 10.1038/nm.4512.
    PubMed     Abstract available

    September 2017
  16. KURUP SP, Obeng-Adjei N, Anthony SM, Traore B, et al
    Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4.
    Nat Med. 2017 Sep 11. doi: 10.1038/nm.4395.
    PubMed     Abstract available

    August 2017
  17. BLASCO B, Leroy D, Fidock DA
    Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
    Nat Med. 2017;23:917-928.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malaria is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.